EYPT EyePoint, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$3,25
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$3,1052 haftanın en düşüğü
$19,0152 haftanın en yükseği
Piyasa Değeri (MRQ)
$276M
P/E (TTM)
-0.9
Hisse Başına Kâr (TTM)
$-3.75
Gelir (TTM)
$3M
rozetleriniz
52 Haftlık Aralık
$3–$19
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$26
P/E
-0.9
ROE
-148.7%
Net Kâr Marjı
-10998.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
EYPT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.25
Piyasa Değeri (MRQ)
$276M
P/E (TTM)
-0.9
Hisse Başına Kâr (TTM)
$-3.75
Gelir (TTM)
$3M
ROE (TTM)
-148.7%
52 Haftlık Aralık
$3–$19
EYPT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 09 Aralık 2020 | 1-for-10 | Ters |
| 11 Haziran 2008 | 1-for-4 | Ters |
EyePoint, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriPharmaceuticals
çalışanlar214
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$31M2017-06-30 → 2025-12-31
Hisse Başına Kâr$-3.172017-06-30 → 2025-12-31
Serbest Nakit Akışı$-243M2019-12-31 → 2025-12-31
Net kar marjı-10998.7%2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | EYPT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.95Y ort. ≈-5.8 | ≈-5.8 | · | · | |
| F/S (TTM) | 99.15Y ort. ≈19.7 | ≈19.7 | 56.0 | Aşırı değerli | |
| F/D (MRQ) | 1.75Y ort. ≈2.8 | ≈2.8 | 1.6 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.05Y ort. ≈-145.0 | ≈-145.0 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.05Y ort. ≈116.8 | ≈116.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.95Y ort. ≈2.9 | ≈2.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | EYPT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -11369.3%5Y ort. ≈-333.3% | ≈-333.3% | -754.4% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -768.6%5Y ort. ≈-331.8% | ≈-331.8% | -390.9% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -738.5%5Y ort. ≈-319.9% | ≈-319.9% | 36.2% | Zayıf | |
| Net Kâr Marjı (TTM) | -10998.7%5Y ort. ≈-320.2% | ≈-320.2% | 9.1% | Zayıf | |
| ROA (TTM) | -115.9%5Y ort. ≈-39.7% | ≈-39.7% | -6.9% | Zayıf | |
| ROE (TTM) | -148.7%5Y ort. ≈-61.0% | ≈-61.0% | -7.6% | Zayıf | |
| ROIC | -79.6%5Y ort. ≈-49.9% | ≈-49.9% | -20.1% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | EYPT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 4.55Y ort. ≈7.4 | ≈7.4 | 11.1 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 8.35Y ort. ≈6.8 | ≈6.8 | 4.5 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | EYPT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -27.5%5Y ort. ≈-0.59% | ≈-0.59% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -8.8%5Y ort. ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -1.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | EYPT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.15Y ort. ≈0.2 | ≈0.2 | 0.1 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$146.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-7.8%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 4, 2026 | $-1.09 | $-0.97 | -12.3% |
| 31 Mart 2026 | $-0.99 | $-0.82 | -20.1% | |
| 31 Aralık 2025 | $-0.81 | $-0.76 | -6.2% | |
| 30 Eylül 2025 | $-0.85 | $-0.80 | -6.2% | |
| 30 Haziran 2025 | $-0.85 | $-0.81 | -4.6% | |
| 31 Mart 2025 | $-0.65 | $-0.67 | 2.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.70 | $4.93 | $5.43 | $2.83 | $5.44 | · | $0.08 | · | · | $0.61 | $0.79 | |
| Revenue / Share | $428.27 | $768.64 | $1.18 | $1.11 | · | · | · | · | · | $0.05 | $0.87 | |
| Cash Flow / Share | $-3277.91 | $-2242.10 | $0.05 | $-1.74 | · | · | · | · | · | $-0.52 | $0.34 | |
| Cash / Share | $1.23 | $1.46 | $5.74 | $2.81 | $5.27 | · | $0.20 | · | · | $0.45 | $0.65 | |
| EPS (TTM) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | $-0.67 | $-0.67 | · | $-0.52 | $-0.68 | $0.21 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | · | 70,168 | 69,926 | 69,767 | · | 54,449 | 53,206 | 52,913,000 | · | 38,341,000 | 37,576,000 | 37,486 | · | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | · | 70,168 | 69,926 | 69,767 | · | 54,449 | 53,206 | 52,913,000 | · | 38,341,000 | 37,576,000 | 37,486 | · | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $2.76 | · | $2.88 | $3.57 | $4.34 | · | $4.09 | $4.38 | $5.01 | · | $1.66 | $1.67 | $2.29 | · | $4.00 | |
| Revenue / Share | $5.86 | $8.09 | · | $13.77 | $76.27 | $0.35 | · | $0.19 | $0.18 | $220.82 | · | $0.40 | $0.24 | $0.20 | · | $0.27 | |
| Cash Flow / Share | · | $-936.63 | · | · | · | $-0.76 | · | · | · | $-589.10 | · | · | · | $-0.45 | · | · | |
| Cash / Share | $1.30 | $0.93 | · | $1.07 | $1.03 | $1.24 | · | $1.49 | $1.74 | $5.43 | · | $3.77 | $4.07 | $3.08 | · | $2.21 | |
| EPS (TTM) | $-3.75 | $-3.51 | · | $-3.00 | $-2.69 | $-2.42 | · | $-1.99 | $-1.78 | $-1.81 | · | $-2.67 | $-2.83 | $-2.74 | · | $-2.18 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $8M | · | $42M | $52M | $56M | · | $46M | $50M | $50M | · | $43M | $37M | $40M | · | $42M | |
| Net Income TTM | $-307M | $-272M | · | $-206M | $-175M | $-147M | · | $-104M | $-87M | $-79M | · | $-100M | $-106M | $-102M | · | $-78M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.7 | · | -4.7 | -3.5 | -2.2 | · | -4.0 | -4.9 | -11.4 | · | -3.0 | -3.1 | -1.1 | · | -3.6 | |
| P/S | 435.9 | 141.3 | · | 23.4 | 12.5 | 6.7 | · | 9.4 | 9.0 | 20.6 | · | 6.6 | 8.0 | 2.5 | · | 6.4 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.4 | 4.2 | 0.3 | · | 3.6 | |
| Earnings Yield | -26.2% | -27.2% | · | -21.1% | -28.6% | -44.6% | · | -24.9% | -20.5% | -8.8% | · | -33.4% | -32.5% | -93.2% | · | -27.6% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $31M | $43M | $46M | $41M | $37M |
| Faaliyet Kâr Marjı % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Net Gelir | $-232M | $-131M | $-71M | $-102M | $-58M |
| Seyreltilmiş Hisse Başı Kâr | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.0 | 0.4 | 0.2 |
| Cari Oran | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Cari Oran | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-243M | $-130M | $-2M | $-67M | $-50M |
Kurumsal Sahipler (13F) 214 dosya · $1.5B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
214
Tutulan Değer
$1.5B
Yeni pozisyonlar
29
Çıkan pozisyonlar
21
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 29 (-33 önceki Ç'ye göre) | 21 (-2 önceki Ç'ye göre) | 66 (-10 önceki Ç'ye göre) | 60 (+22 önceki Ç'ye göre) | +2.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 8,06% | Hisse senetleri |
| BlackRock, Inc. | $106.723.718 | 7.463.197 | 7,25% | Hisse senetleri |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 6,80% | Hisse senetleri |
| VANGUARD GROUP INC | $88.100.480 | 4.822.139 | 5,99% | Hisse senetleri |
| FEDERATED HERMES, INC. | $81.239.044 | 5.681.052 | 5,52% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 4,69% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $68.741.215 | 4.807.078 | 4,67% | Hisse senetleri |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 4,47% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 3,53% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $46.419.056 | 3.601.168 | 3,15% | Hisse senetleri |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 2,81% | Hisse senetleri |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,29% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $29.497.382 | 2.062.390 | 2,00% | Hisse senetleri |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 1,95% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 1,94% | Satım opsiyonu |
| CITADEL ADVISORS LLC | $28.279.823 | 1.977.610 | 1,92% | Hisse senetleri |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 1,76% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,25% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,21% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,15% | Hisse senetleri |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,05% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,04% | Hisse senetleri |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,02% | Hisse senetleri |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 0,96% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 0,94% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $12.132.298 | 848.410 | 0,82% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $12.035.896 | 841.746 | 0,82% | Hisse senetleri |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 0,81% | Hisse senetleri |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,76% | Hisse senetleri |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,75% | Hisse senetleri |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,74% | Hisse senetleri |
| NORTHERN TRUST CORP | $10.309.113 | 720.917 | 0,70% | Hisse senetleri |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,70% | Hisse senetleri |
| Principia Wealth Advisory, LLC | $9.293.530 | 649.944 | 0,63% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,63% | Hisse senetleri |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,61% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,54% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,54% | Alım opsiyonu |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,50% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,49% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $6.650.744 | 465.087 | 0,45% | Hisse senetleri |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,39% | Hisse senetleri |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,36% | Alım opsiyonu |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,36% | Satım opsiyonu |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,34% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,33% | Hisse senetleri |
| MORGAN STANLEY | $4.815.240 | 336.730 | 0,33% | Hisse senetleri |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,32% | Hisse senetleri |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,31% | Hisse senetleri |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,31% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 başvurular | 08 Aralık 2023 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 30 Ağustos 2023 | · | İlk başvuru | · | SEC |
| Ocumension Therapeutics | 22 Ocak 2021 | · | İlk başvuru | · | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 başvurular | 26 Mayıs 2017 | · | İlk başvuru | · | SEC |
| Pfizer Inc. | 17 Temmuz 2007 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 34 içeriden öğrenenler · 14 yöneticiler · 22 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 Temmuz 2026 M | 9.594 | 1 | 0 | $19.725 |
| Paul Ashton | President & CEO | 18 Mart 2016 M | 450.741 | 0 | 0 | $0 |
| George Elston | Chief Financial Officer | 20 Ağustos 2026 G | 64.953 | 0 | 0 | $0 |
| David Price | CFO | 25 Haziran 2019 A | · | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 Eylül 2008 A | · | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 Haziran 2026 M | 0 | 0 | 7 | $-948.955 |
| Dario A. Paggiarino | Chief Medical Officer | 30 Mart 2024 M | 67.080 | 0 | 0 | $0 |
| David Scott Jones | SVP & Chief Commercial Officer | 09 Şubat 2024 M | 44.916 | 0 | 0 | $0 |
| Michael Craig Pine | Chief Corp Dev.&Strat. Officer | 06 Ocak 2024 M | 13.662 | 0 | 0 | $0 |
| Leonard S Ross | VP Finance and Chief Accounting Officer | 27 Haziran 2019 M | 90.044 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 Mayıs 2018 A | · | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 Haziran 2017 A | · | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 Temmuz 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 Ekim 2007 A | · | 0 | 0 | $0 |
| Karen L. Zaderej | Yönetim kurulu üyesi | 18 Ağustos 2026 P | 49.100 | 1 | 0 | $52.258 |
| Nancy Lurker | Yönetim kurulu üyesi | 06 Ocak 2026 M | 294.346 | 0 | 3 | $-150.988 |
| Reginald J. Sanders | Yönetim kurulu üyesi | 02 Ocak 2026 A | · | 0 | 0 | $0 |
| Stuart Duty | Yönetim kurulu üyesi | 02 Ocak 2026 A | · | 0 | 0 | $0 |
| John B. Landis | Yönetim kurulu üyesi | 02 Ocak 2026 A | 21.400 | 0 | 0 | $0 |
| Wendy F Dicicco | Yönetim kurulu üyesi | 02 Ocak 2026 A | 9.967 | 0 | 0 | $0 |
| ANDO GORAN | Yönetim kurulu üyesi | 02 Ocak 2026 A | 13.150 | 0 | 0 | $0 |
| Fred Hassan | Yönetim kurulu üyesi | 02 Ocak 2026 A | · | 0 | 0 | $0 |
| David R Guyer | Yönetim kurulu üyesi | 12 Temmuz 2024 M | 1.850 | 0 | 0 | $0 |
| Anthony P Adamis | Yönetim kurulu üyesi | 23 Haziran 2024 M | 4.000 | 0 | 0 | $0 |
| Ye Liu | Yönetim kurulu üyesi | 11 Ocak 2024 S | 100.221 | 0 | 0 | $0 |
| OcuMension Therapeutics | Yönetim kurulu üyesi | 11 Ocak 2024 S | 100.221 | 0 | 0 | $0 |
| Douglas Evan Godshall | Yönetim kurulu üyesi | 22 Haziran 2021 A | 8.016 | 0 | 0 | $0 |
| Kristine Peterson | Yönetim kurulu üyesi | 28 Şubat 2020 A | 6.667 | 0 | 0 | $0 |
| David J Mazzo | Yönetim kurulu üyesi | 09 Ekim 2019 M | 200.083 | 0 | 0 | $0 |
| Michael W Rogers | Yönetim kurulu üyesi | 25 Haziran 2019 A | 119.167 | 0 | 0 | $0 |
| James J Barry | Yönetim kurulu üyesi | 07 Mayıs 2018 M | 12.500 | 0 | 0 | $0 |
| SAVAS PETER G | Yönetim kurulu üyesi | 03 Aralık 2015 A | · | 0 | 0 | $0 |
| Paul Hopper | Yönetim kurulu üyesi | 18 Aralık 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Yönetim kurulu üyesi | 27 Kasım 2007 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 30 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,13% | 19.051 NS | 31 Temmuz 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,63% | 23.853 NS | 31 Temmuz 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,38% | 26.636 SH | 02 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,08% | 263.363 SH | 11 Eylül 2026 | Günlük |
| IHE · iShares Trust | 0,08% | 290.098 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86.797 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69.310 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 36.951 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445.218 SH | 19 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 5.967 SH | 02 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,02% | 607.108 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,02% | 207.955 NS | 31 Temmuz 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 35.128 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.984.162 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901.417 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.210 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 213.549 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 60.232 SH | 02 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,00% | 4.573 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,00% | 5.922 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 48.608 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 16.256 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.657 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 22.216 SH | 03 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.643.860 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.035 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 121.398 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 3.155 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 15.627 SH | 11 Eylül 2026 | Günlük |
EYPT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 19 analist
AL
Medyan hedef
$20.00
+515,4%
6 31,6%
Güçlü Al
7 36,8%
Al
6 31,6%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
11 analist · 2026-09-30Ortalama hedef $25.91 +697,2%
← Tüm hedeflerin altında
Mevcut fiyat $3.25
Düşük$4.00
Ortalama$25.91
Yüksek$68.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | · |
| BIOA | $495M | -5.9 | · | -896.1% | -28.4% | · |
| FULC | $753M | -9.6 | 2752.0% | · | -26.6% | · |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | · |
| ANTX | $31M | -1.0 | · | · | -57.7% | · |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026